Prkca Protein (Protein Kinase C Alpha) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Prkca Protein (Protein Kinase C Alpha) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Prkca Protein (Protein Kinase C Alpha) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@pkc2007]
[@protein2004]
PRKCA (Protein Kinase C Alpha) is a member of the protein kinase C (PKC) family of serine/threonine kinases. It is a conventional PKC isoform requiring calcium, phosphatidylserine, and diacylglycerol (DAG) for activation. [@role]
Protein Overview
Structure
PRKCA contains multiple functional domains:
N-terminal regulatory domain: Contains the C1 domain (binds DAG/phorbol esters) and C2 domain (binds calcium/phosphatidylserine)
C-terminal catalytic domain: Contains the kinase domain with ATP-binding site
Isoforms
Multiple isoforms exist due to alternative splicing, with the full-length isoform being the most studied in neuronal systems.
Function
Normal Cellular Functions
Signal transduction: Mediates responses to extracellular signals via G-protein-coupled receptors and receptor tyrosine kinases
Synaptic plasticity: Critical for learning and memory processes; regulates AMPA receptor trafficking
Prkca Protein (Protein Kinase C Alpha) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Prkca Protein (Protein Kinase C Alpha) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, Protein kinase C in Alzheimer's disease: potential for targeted therapy (n.d.)](https://doi.org/10.1016/S0197-4580(02)
[Unknown, PKC and synaptic plasticity in Alzheimer's disease (2007)](https://doi.org/10.1016/j.neurobiolaging.2007.10.016)
[Unknown, Protein kinase C alpha and Alzheimer's disease (2004)](https://doi.org/10.1016/j.neurobiolaging.2004.11.009)
[Unknown, Role of PKC in neuronal survival and death (n.d.)](https://doi.org/10.1016/S0166-2236(03)
[Unknown, PKC in learning and memory (n.d.)](https://doi.org/10.1016/S0166-2236(03)
[Unknown, Protein kinase C isozymes: regulation and function (2010)](https://doi.org/10.1111/j.1742-4658.2010.07665.x)
[Unknown, Tau phosphorylation by protein kinase C (n.d.)](https://doi.org/10.1042/0264-6021:3530313)
[Unknown, PKC and dopamine signaling in Parkinson's disease (2020)](https://doi.org/10.1016/j.neuropharm.2020.107999)